Roche Pipeline Focus Includes Cognitive, Cardiovascular Benefits
This article was originally published in The Tan Sheet
Executive Summary
Roche Vitamins' commercialization of new ingredients targeting cognitive function and cardiovascular health is possible by late 2002. The firm is studying the cognitive benefits of a botanical substance under the proprietary name Nateca.
You may also be interested in...
Martek Nutritional Oils Addition To U.S. Infant Formulas Forthcoming
FDA's long-awaited affirmation that Martek Biosciences' nutritional oils are generally recognized as safe came May 17, giving the firm an entry into the approximately $2 bil. U.S. infant formula market.
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands